DSM-Firmenich AG

47
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1216478797
EUR
60.50
-0.2 (-0.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
DSM-Firmenich AG Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
No of Months
12
12
12
12
12
Profit Before Tax
568.00
423.00
-647.00
594.00
645.00
Adjustment
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-210.00
198.00
160.00
-497.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,418.00
1,758.00
1,274.00
923.00
0.00
Cash Flow from Investing Activities
362.00
-325.00
-795.00
871.00
0.00
Cash Flow from Financing Activities
-2,582.00
-1,241.00
-760.00
-598.00
0.00
Net Cash Inflow / Outflow
-874.00
211.00
-299.00
1,194.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-72.00
19.00
-18.00
-2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of DSM-Firmenich AG
Figures in Million
Markets Mojo
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -19.34% vs 37.99% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
1,418.00
1,758.00
-19.34%